Please find attached.

IGL/SE/2026-27/29 24th July, 2026 The Manager (Listing) The Manager (Listing) BSE Limited National Stock Exchange of India Limited 1st Floor, New Trading Ring, Exchange Plaza, C-1, Block G, Rotunda Building, P.J. Towers, Bandra Kurla Complex, Dalal Street, Bandra (East) Mumbai- 400 001 Mumbai – 400 051 Scrip Code: 500201 Symbol: INDIAGLYCO Dear Sirs, Sub: Business Responsibility and Sustainability Report for the Financial Year 2025-26 Pursuant to Regulation 34(2)(f) of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations 2015, we are submitting herewith the Business Responsibility and Sustainability Report (‘BRSR’) for FY 2025-26 which forms part of the Annual Report FY 2025-26. This is for your information and record. Thanking you, Yours truly, For India Glycols Limited Ankur Jain Head (Legal) & Company Secretary Encl: A/a Business Responsibility and Sustainability Report SECTION A: GENERAL DISCLOSURES I. Details of the listed entity 1 Corporate Identity Number (CIN) of the Listed Entity L24111UR1983PLC009097 2 Name of the Listed Entity India Glycols Limited 3 Year of incorporation 1983 4 Registered office address A-1, Industrial Area, Bazpur Road, Kashipur- 244713, Dist. Udham Singh Nagar, Uttarakhand 5 Corporate address Corporate Office - 3A, Shakespeare Sarani, Kolkata - 700 071 Head Office - Plot No. 2-B, Sector-126, Noida - 201304 Distt. Gautam Budh Nagar, Uttar Pradesh 6 E-mail compliance.officer@indiaglycols.com 7 Telephone 0120-6860000/ 3090100/ 3090200 8 Website www.indiaglycols.com 9 Financial year for which reporting is being done 1st April, 2025 to 31st March, 2026 10 Name of the Stock Exchange(s) where BSE Limited ("BSE") and National Stock Exchange of India shares are listed Limited ("NSE") 11 Paid-up Capital 33,51,33,825/-* 12 Name and contact details (telephone, e-mail address) of Shri Alok Singhal the person who may be contacted in case of any queries Telephone: 05947-269000/ 269500 on the BRSR report E-mail id: alok.singhal@indiaglycols.com 13 Reporting boundary - Are the disclosures under this report Standalone basis made on a standalone basis (i.e. only for the entity) or on a consolidated basis (i.e. for the entity and all the entities which form a part of its consolidated financial statements, taken together) 14 Name of assessment or assurance provider Not Applicable 15 Type of assessment or assurance obtained Not Applicable *Pursuant to allotment of 51,03,765 equity shares, of face value of 5/- each, on preferential basis, on 24th November 2025, the paid-up share capital was increased from 30,96,15,000 to 33,51,33,825. II. Products/services 16 Details of business activities (accounting for 90% of the turnover): S. Description of Main Activity Description of Business Activity % of Turnover No. of the entity 1 Bio-Based Specialities and Manufacturing, sales and marketing of: 11.60% Performance Chemicals o Bio-based Glycols (MEG, DEG, TEG and Heavy Glycols), Glycol Ethers, Glycol Ether Acetates. o Bio-based Ethylene Oxide. o Industrial Gases, Bio Polymers etc. 2 Potable Spirits Manufacturing, sales and marketing of Potable Spirits - Indian Made Foreign 68.74% Liquor ("IMFL"), Branded Country Liquor and Extra Neutral Alcohol ("ENA"). 3 Ennature Bio-pharma Manufacturing, sales and marketing of Nutraceuticals and API. 2.09% 4 Bio-fuel Power Alcohol (DAE) 14.96% 17 Products/Services sold by the entity (accounting for 90% of the entity's Turnover): S. Product/Service NIC Code % of total Turnover No. contributed 1 Glycols & Others 20119 10.74% 2 Power Alcohol (DAE) (Bio-fuels) 20119 14.96% 3 Guar Gum Powder and Derivatives (Bio Polymers) 20119 0.39% 4 Ethyl Alcohol (Potable) 1101 68.74% 5 Industrial Gases 20111 0.47% 6 Chemicals and Oil Products 20119 1.94% 7 Nutraceuticals 21001 2.09% III. Operations 18. Number of locations where plants and/or operations/offices of the entity are situated: Location Number of plants Number of offices Total National 3 4 7 *International 0 0 0 * We undertake business activities in USA and South East Asia (through subsidiary companies). 19. Markets served by the entity: a. Number of locations Locations Number National (No. of States) 26 States and 6 Union Territories International (No. of Countries) 48 b. What is the contribution of exports as a percentage of the total turnover of the entity? 5.11% c. A brief on types of customers: The Company offers a wide and diversified product portfolio catering to multiple end- use applications. Accordingly, its customer base is equally diverse, ranging from large corporates to medium and small enterprises, as well as traders and distributors, depending on the dynamics of the respective end markets. Bio-Based Specialities and Performance Chemicals Under this segment, the Company serves a broad industrial customer base, including manufacturers across industries such as PET, polyester fiber, paints, solvents and coatings, oilfield chemicals, textiles, beverages, automotive (coolants and brake fluids), EO derivatives and food and animal nutrition (poultry, cattle and aquaculture). Ennature Biopharma (Nutraceuticals/API) This segment is focused on the health and wellness sector, supplying high-quality Active Pharmaceutical Ingredients (APIs) to pharmaceutical companies and botanical extracts to nutraceutical players. It also manufactures nicotine for the pharmaceutical industry and products designed for smoking cessation. Potable Sprits Products in this segment are primarily targeted at retail end consumers. Extra Neutral Alcohol (ENA) ENA is supplied directly to end-users in the potable liquor, perfumery and pharmaceutical industries. Bio Fuel The Company supplies ethanol to Oil Manufacturing Companies under the Ethanol Blended Petrol (EBP) Programme, contributing to cleaner and sustainable fuel initiatives. IV. Employees 20. Details as at the end of Financial Year: a. Employees and workers (including differently abled): S. Particulars Total Male Female No. (A) No. (B) % (B / A) No. (C) % (C / A) EMPLOYEES 1 Permanent (D) 945 907 95.98% 38 4.02% 2 Other than Permanent (E) 338 327 96.75% 11 3.25% 3 Total employees (D + E) 1,283 1,234 96.18% 49 3.82% WORKERS 4 Permanent (F) 455 455 100.00% 0 0.00% 5 Other than Permanent (G) 2,213 2,054 92.82% 159 7.18% 6 Total workers (F + G) 2,668 2,509 94.04% 159 5.96% b. Differently abled Employees and workers: S. Particulars Total Male Female No. (A) No. (B) % (B / A) No. (C) % (C / A) DIFFERENTLY ABLED EMPLOYEES 1 Permanent (D) 1 1 100% 0 0.00% 2 Other than Permanent (E) 1 1 100% 0 0.00% 3 Total differently abled employees (D + E) 2 2 100% 0 0.00% DIFFERENTLY ABLED WORKERS 4 Permanent (F) 0 0 0.00% 0 0.00% 5 Other than Permanent (G) 0 0 0.00% 0 0.00% 6 Total differently abled workers (F + G) 0 0 0.00% 0 0.00% 21. Participation/Inclusion/Representation of women Total No. and percentage of females (A) No. (B) % (B / A) Board of Directors 8 3 37.50% Key Management Personnel 3 0 0.00% 22. Turnover rate for permanent employees and workers FY 2025-26 FY 2024-25 FY 2023-24 Male Female Total Male Female Total Male Female Total Permanent Employees 15% 16% 15% 14% 23% 14% 19% 24% 19% Permanent Workers 12% 0% 12% 11% 0% 11% 8% 0% 8% V. Holding, Subsidiary and Associate Companies (including joint ventures) 23. a) Names of holding / subsidiary / associate companies / joint ventures S. Name of the holding / Indicate whether % of shares held Does the entity indicated at No. subsidiary / associate holding/ Subsidiary/ by listed entity column A, participate in the companies / joint ventures (A) Associate/ Joint Business Responsibility Venture initiatives of the listed entity? (Yes/No) 1. Kashipur Holdings Limited* Holding* - No 2. IGL Spirits Limited Subsidiary 100% No 3. Ennature Bio Pharma Limited Subsidiary 100% No 4. IGL Finance Limited Subsidiary 100% No 5. IGL Chemicals and Services Subsidiary 100% No Private Limited 6. IGL Chem International USA LLC Subsidiary 100% No 7. IGL Chem Internati [Showing first 8,000 characters — download PDF for full document]